Bubs Australia Ltd (BUB)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 0.096 |
|---|---|
| 52-week range | 0.076 – 0.165 |
| Return, 1 month / 3 months | −20.0% / +23.1% |
| Return, 1 year / 3 years | −31.4% / −45.1% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 56.5% |
| Worst drawdown (1 year) | -53.3% |
| Average daily value traded | 0.21M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bubs Australia is an Australian maker of infant nutrition and dairy products. It produces infant formula, including goat milk formula, along with baby food pouches and cereals for young children. The company also offers goat milk products for adults. Its customers are parents and caregivers, and its goods are sold in Australian retailers and exported to overseas markets, particularly in Asia. Bubs Australia is based in Australia and develops its products around goat milk and organic ingredients.
On this site Bubs Australia Ltd appears as a stock on the Australian Securities Exchange (Australia), code BUB, with prices in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bubs Australia Ltd (BUB) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.096 on 19 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 598 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 31.4% and over the last three months it rose 23.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -7.2% | ||
| From 52-week high | -41.8% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 23.1% | ||
| 6-month return | -4.0% | ||
| 12-month return, skipping the last month | -14.3% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 56.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -53.3% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.21M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.0% |
|---|---|
| 1 month | −20.0% |
| 3 months | +23.1% |
| 6 months | −4.0% |
| 1 year | −31.4% |
| 3 years | −45.1% |
| 5 years | −80.5% |
Signals
| 50-day / 200-day average | 0.101 / 0.103 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.005 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.